Skip to main content
. 2022 Jul 7;23(14):7541. doi: 10.3390/ijms23147541

Figure 3.

Figure 3

(a) Evidence of significant increase of CB1 in NSC-34 after treatment with CBNR; (b) GAPDH used for normalization; (c) densitometric analysis of CB1, ** p < 0.005. **** p < 0.0001; (d) Evidence of different phosphorylation degree of ERK at different doses; (e) not-phosphorylated ERK used for normalization; (f) densitometric analysis of p-ERK, * p < 0.05. *** p = 0.0001. **** p < 0.0001; (g) Evidence of different phosphorylation degree of Akt at different doses; (h) non-phosphorylated Akt used for normalization; (i) densitometric analysis of p-Akt, * p < 0.05. ** p < 0.005. **** p < 0.0001; (j) Evidence of different phosphorylation degree of rps6 at different doses; (k) non-phosphorylated rps6 used for normalization; (l) densitometric analysis of p-rps6, **** p < 0.0001.